Finance

Lists
DDNB34:BVMF
Dupont De Nemours Inc BDR
R$678,64
-0,20%
(-1,36) 1D
29 Sep., 11:00:04 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DDNB34...
Open
R$678,64
High
R$678,64
Low
R$678,64
Mkt. cap
17,54 mjd
Avg. vol.
33,00
Volume
2,00
52-wk high
R$1 304,54
52-wk low
R$597,12
Shares outstanding
135,04 m
No. of employees
15 k
Open
R$678,64
High
R$678,64
Low
R$678,64
Mkt. cap
17,54 mjd
Avg. vol.
33,00
Volume
2,00
52-wk high
R$1 304,54
52-wk low
R$597,12
Shares outstanding
135,04 m
No. of employees
15 k
News stories
From web sources and news partners
Profile
DuPont de Nemours, Inc., commonly shortened to DuPont, is a company headquartered and organized in Delaware that produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company operates two divisions: Healthcare & Water Technologies, which produces medical packaging such as Tyvek packaging and Tychem protective suits as well as Amberlite ion exchange resins, Filmtec reverse osmosis and nanofiltration elements and Inge and Itegratec ultrafiltration modules; and Diversified Industrials, which produces products for repair‑and‑remodel construction such as Tyvek house wrap, Styrofoam insulation, Corian, Vespel shapes and parts, Molykote lubricants, Betaforce, and Betaseal. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder. Wikipedia
About Dupont De Nemours Inc BDR
CEOLori Koch
Employees15 k
Founded31 Aug. 2017
Headquarters-
SectorConglomerate
Websitedupont.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,07 mjd
-1,87 mjd
1,68 mjd
1,82 mjd
Cost of goods sold
1,88 mjd
-816,00 m
1,08 mjd
1,18 mjd
Cost of revenue
1,88 mjd
-816,00 m
1,08 mjd
1,18 mjd
Research and development expenses
140,00 m
-211,00 m
47,00 m
42,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
388,00 m
-111,00 m
255,00 m
270,00 m
Operating expense
649,00 m
-406,00 m
370,00 m
380,00 m
Total operating expenses
2,53 mjd
-1,22 mjd
1,45 mjd
1,56 mjd
Operating income
546,00 m
-649,00 m
232,00 m
259,00 m
Other non operating income
5,00 m
-46,00 m
10,00 m
4,00 m
EBT including unusual items
327,00 m
-738,00 m
181,00 m
266,00 m
EBT excluding unusual items
482,00 m
-719,00 m
221,00 m
262,00 m
Income tax expense
19,00 m
-89,00 m
31,00 m
75,00 m
Effective tax rate
5,81%
12,06%
17,13%
28,20%
Other operating expenses
-
-
-
-
Net income
-123,00 m
-126,00 m
161,00 m
143,00 m
Net profit margin
-4,00%
6,73%
9,58%
7,86%
Earnings per share
3,27
1,38
1,65
1,88
Interest and investment income
27,00 m
30,00 m
10,00 m
27,00 m
Interest expense
-99,00 m
-16,00 m
-40,00 m
-41,00 m
Net interest expenses
-72,00 m
14,00 m
-30,00 m
-14,00 m
Depreciation and amortization charges
-
-84,00 m
-
-
EBITDA
729,00 m
-487,25 m
387,00 m
413,00 m
Gain or loss from assets sale
-
-3,00 m
-
-
AI content may include mistakes. Learn more
Google-programme